The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells

Endothelial cells lining the blood vessels are principal players in vascular inflammatory responses. Dysregulation of endothelial cell function caused by hyperglycemia, dyslipidemia, and hyperinsulinemia often result in impaired vasoregulation, oxidative stress, inflammation, and altered barrier function. Various stressors including high glucose stimulate the release of nucleotides thus initiating signaling via purinergic receptors. However, purinergic modulation of inflammatory responses in endothelial cells caused by high glucose and palmitate remains unclear. In the present study, we investigated whether the effect of high glucose and palmitate is mediated by P2X7 and P2X4 and if they play a role in endothelial cell dysfunction. Transcript and protein levels of inflammatory genes as well as reactive oxygen species production, endothelial-leukocyte adhesion, and cell permeability were investigated in human umbilical vein endothelial cells exposed to high glucose and palmitate. We report high glucose and palmitate to increase levels of extracellular ATP, expression of P2X7 and P2X4, and inflammatory markers. Both P2X7 and P2X4 antagonists inhibited high glucose and palmitate-induced interleukin-6 levels with the former having a significant effect on interleukin-8 and cyclooxygenase-2. The effect of the antagonists was confirmed with siRNA knockdown of the receptors. In addition, P2X7 mediated both high glucose and palmitate-induced increase in reactive oxygen species levels and decrease in endothelial nitric oxide synthase. Blocking P2X7 inhibited high glucose and palmitate-induced expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 as well as leukocyte-endothelial cell adhesion. Interestingly, high glucose and palmitate enhanced endothelial cell permeability that was dependent on both P2X7 and P2X4. Furthermore, antagonizing the P2X7 inhibited high glucose and palmitate-mediated activation of p38-mitogen activated protein kinase. These findings support a novel role for P2X7 and P2X4 coupled to induction of inflammatory molecules in modulating high glucose and palmitate-induced endothelial cell activation and dysfunction.

[1]  B. Olde,et al.  Correction: The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells , 2015, PloS one.

[2]  B. Olde,et al.  Shear stress modulates endothelial KLF2 through activation of P2X4 , 2015, Purinergic Signalling.

[3]  Pingsheng Liu,et al.  Cyclooxygenase-2-dependent oxidative stress mediates palmitate-induced impairment of endothelium-dependent relaxations in mouse arteries. , 2014, Biochemical pharmacology.

[4]  Philip Smith,et al.  Plasma Membrane Cholesterol as a Regulator of Human and Rodent P2X7 Receptor Activation and Sensitization* , 2014, The Journal of Biological Chemistry.

[5]  John H. Zhang,et al.  P2X7 Receptor Antagonism Inhibits p38 Mitogen-Activated Protein Kinase Activation and Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats , 2013, Critical care medicine.

[6]  S. Menini,et al.  The purinergic 2X7 receptor participates in renal inflammation and injury induced by high‐fat diet: possible role of NLRP3 inflammasome activation , 2013, The Journal of pathology.

[7]  R. Webb,et al.  P2X7 receptor activation contributes to an initial upstream mechanism of lipopolysaccharide-induced vascular dysfunction. , 2013, Clinical science.

[8]  Chul Hee Choi,et al.  P2X4 Assembles with P2X7 and Pannexin-1 in Gingival Epithelial Cells and Modulates ATP-induced Reactive Oxygen Species Production and Inflammasome Activation , 2013, PloS one.

[9]  H. Xiong,et al.  High fatty acids modulate P2X7 expression and IL-6 release via the p38 MAPK pathway in PC12 cells , 2013, Brain Research Bulletin.

[10]  T. Pawełczyk,et al.  High glucose concentration impairs ATP outflow and immunoglobulin production by human peripheral B lymphocytes: involvement of P2X7 receptor. , 2013, Immunobiology.

[11]  Hua Xu,et al.  Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways. , 2013, Journal of molecular endocrinology.

[12]  C. Stehouwer,et al.  Endothelial dysfunction in (pre)diabetes: Characteristics, causative mechanisms and pathogenic role in type 2 diabetes , 2013, Reviews in Endocrine and Metabolic Disorders.

[13]  J. Yerbury,et al.  P2X7 Receptor Activation Induces Reactive Oxygen Species Formation and Cell Death in Murine EOC13 Microglia , 2013, Mediators of inflammation.

[14]  Jiawei Chen,et al.  Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells , 2013, Cardiovascular Diabetology.

[15]  M. Sitkovsky,et al.  Purinergic signaling during inflammation. , 2012, The New England journal of medicine.

[16]  P. Dagnelie,et al.  The P2X7 loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levels , 2012, BMC Immunology.

[17]  C. Müller,et al.  N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists. , 2012, Journal of medicinal chemistry.

[18]  E. Abel,et al.  Mechanisms of Lipotoxicity in the Cardiovascular System , 2012, Current Hypertension Reports.

[19]  Eunjung Kim,et al.  Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators , 2012, Autoimmune diseases.

[20]  F. Di Virgilio,et al.  P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  O. Melander,et al.  A Common Missense Variant in the ATP Receptor P2X7 Is Associated with Reduced Risk of Cardiovascular Events , 2012, PloS one.

[22]  J. Oyama,et al.  glucagon-like peptide 1 analog liraglutide reduces TNF-- induced oxidative tress and inflammation in endothelial cells , 2012 .

[23]  Michael W. Salter,et al.  ATP receptors gate microglia signaling in neuropathic pain , 2012, Experimental Neurology.

[24]  T. Takenouchi,et al.  Involvement of P2X4 receptor in P2X7 receptor-dependent cell death of mouse macrophages. , 2012, Biochemical and biophysical research communications.

[25]  B. Khakh,et al.  Imaging P2X4 Receptor Lateral Mobility in Microglia , 2012, The Journal of Biological Chemistry.

[26]  Y. de Koninck,et al.  P2X4 Receptors Influence Inflammasome Activation after Spinal Cord Injury , 2012, The Journal of Neuroscience.

[27]  C. Kim,et al.  Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells. , 2011, Biochemical and biophysical research communications.

[28]  G. Dubyak,et al.  Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1. , 2011, American journal of physiology. Cell physiology.

[29]  S. Merali,et al.  Infusion of Glucose and Lipids at Physiological Rates Causes Acute Endoplasmic Reticulum Stress in Rat Liver , 2011, Obesity.

[30]  R. Unwin,et al.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases , 2011, Expert opinion on investigational drugs.

[31]  Denis Gris,et al.  Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.

[32]  G. Boden.  Obesity, insulin resistance and free fatty acids , 2011, Current opinion in endocrinology, diabetes, and obesity.

[33]  T. Kodama,et al.  Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. , 2011, Cell metabolism.

[34]  L. Joosten,et al.  Hyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1β Transcription in Human Adipose Tissue , 2011, Diabetes.

[35]  J. Vargas-Morales,et al.  Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. , 2011, Cellular immunology.

[36]  M. Heni,et al.  Inflammatory response of human coronary artery endothelial cells to saturated long-chain fatty acids. , 2011, Microvascular research.

[37]  K. Dellsperger,et al.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update , 2011, Basic Research in Cardiology.

[38]  T. Uchiyama,et al.  The role of endothelial interleukin‐8/NADPH oxidase 1 axis in sepsis , 2010, Immunology.

[39]  E. Agardh,et al.  Vascular Cellular Adhesion Molecule-1 (VCAM-1) Expression in Mice Retinal Vessels Is Affected by Both Hyperglycemia and Hyperlipidemia , 2010, PloS one.

[40]  H. Hirbec,et al.  P2X4 receptors mediate PGE2 release by tissue‐resident macrophages and initiate inflammatory pain , 2010, The EMBO journal.

[41]  James D. Johnson,et al.  Glucose-induced endothelial heparanase secretion requires cortical and stress actin reorganization. , 2010, Cardiovascular research.

[42]  L. Rodríguez-Mañas,et al.  Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo , 2010, PloS one.

[43]  N. Hamburg,et al.  Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications , 2010, Reviews in Endocrine and Metabolic Disorders.

[44]  H. Kaneto,et al.  Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis , 2010, Mediators of inflammation.

[45]  H. Langer,et al.  Leukocyte – endothelial interactions in inflammation , 2009, Journal of cellular and molecular medicine.

[46]  K. Maedler,et al.  Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival , 2009, Diabetologia.

[47]  S. Beggs,et al.  P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase Activation , 2009, The Journal of Neuroscience.

[48]  H. Arnesen,et al.  Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome , 2009, Diabetes Care.

[49]  M. Lisanti,et al.  ICAM-1: role in inflammation and in the regulation of vascular permeability. , 2008, American journal of physiology. Heart and circulatory physiology.

[50]  Yan Tang,et al.  Selective up-regulation of P2X4-receptor gene expression by interferon-gamma in vascular endothelial cells. , 2008, Journal of pharmacological sciences.

[51]  A. Michel,et al.  Agonist potency at P2X7 receptors is modulated by structurally diverse lipids , 2007, British journal of pharmacology.

[52]  R. Stocker,et al.  Hydrogen Peroxide Promotes Endothelial Dysfunction by Stimulating Multiple Sources of Superoxide Anion Radical Production and Decreasing Nitric Oxide Bioavailability , 2007, Cellular Physiology and Biochemistry.

[53]  S. Dower,et al.  P2X receptor characterization and IL‐1/IL‐1Ra release from human endothelial cells , 2007, British journal of pharmacology.

[54]  Zhenqi Liu,et al.  p38 Mitogen-Activated Protein Kinase Mediates Palmitate-Induced Apoptosis But Not Inhibitor of Nuclear Factor-κB Degradation in Human Coronary Artery Endothelial Cells , 2007 .

[55]  F. Mach,et al.  The specific role of chemokines in atherosclerosis , 2007, Thrombosis and Haemostasis.

[56]  Zhenqi Liu,et al.  p38 mitogen-activated protein kinase mediates palmitate-induced apoptosis but not inhibitor of nuclear factor-kappaB degradation in human coronary artery endothelial cells. , 2007, Endocrinology.

[57]  M. Braddock,et al.  Characterization of a selective and potent antagonist of human P2X7 receptors, AZ11645373 , 2006, British journal of pharmacology.

[58]  H. Häring,et al.  Saturated, but Not Unsaturated, Fatty Acids Induce Apoptosis of Human Coronary Artery Endothelial Cells via Nuclear Factor-κB Activation , 2006, Diabetes.

[59]  B. Khakh,et al.  P2X receptors as cell-surface ATP sensors in health and disease , 2006, Nature.

[60]  G. Weisman,et al.  P2 receptors in atherosclerosis and postangioplasty restenosis , 2006, Purinergic Signalling.

[61]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[62]  C. Brosnan,et al.  The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytes , 2005, Glia.

[63]  N. Stefan,et al.  Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. , 2004, Diabetes.

[64]  R. Sluyter,et al.  P2X7 receptor polymorphism impairs extracellular adenosine 5′-triphosphate-induced interleukin-18 release from human monocytes , 2004, Genes and Immunity.

[65]  F. Di Virgilio,et al.  Enhanced P2X7 Activity in Human Fibroblasts From Diabetic Patients: A Possible Pathogenetic Mechanism for Vascular Damage in Diabetes , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[66]  D. Hall,et al.  The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho , 2004, Journal of leukocyte biology.

[67]  D. Puro,et al.  Enhancement of P2X(7)-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature. , 2004, Investigative ophthalmology & visual science.

[68]  G. Dubyak,et al.  Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanisms , 2003, British journal of pharmacology.

[69]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[70]  P. Insel,et al.  Hypertonic Stress Increases T Cell Interleukin-2 Expression through a Mechanism That Involves ATP Release, P2 Receptor, and p38 MAPK Activation* , 2003, The Journal of Biological Chemistry.

[71]  C. Gabel,et al.  Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response , 2002, The Journal of Immunology.

[72]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[73]  G. Burnstock,et al.  P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells , 2002, Cellular and Molecular Life Sciences CMLS.

[74]  C. Flores,et al.  Inhibition of Nitrobenzylthioinosine-Sensitive Adenosine Transport by Elevated d-Glucose Involves Activation of P2Y2 Purinoceptors in Human Umbilical Vein Endothelial Cells , 2002, Circulation research.

[75]  F. Virgilio,et al.  P2 receptors: new potential players in atherosclerosis , 2002, British journal of pharmacology.

[76]  Beverly H. Koller,et al.  Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.

[77]  S. Kado,et al.  Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus , 1999, Acta Diabetologica.

[78]  G. Burnstock,et al.  Increased release of ATP from endothelial cells during acute inflammation , 1998, Inflammation Research.

[79]  G. Dubyak,et al.  Modulation of P2X7 nucleotide receptor expression by pro‐ and anti‐inflammatory stimuli in THP‐1 monocytes , 1998, Journal of leukocyte biology.

[80]  P. Vallance,et al.  Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? , 1997, The Lancet.

[81]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.